Vaccitech plc - ADR

+0.07 (+2.93%)
4:10:01 PM EDT: $2.46 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)94.36M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.7 Million
Adjusted EPS-$0.55
See more estimates
10-Day MA$2.44
50-Day MA$2.38
200-Day MA$2.77
See more pivots

Vaccitech plc - ADR Stock, NASDAQ:VACC

Zeus Building, Rutherford Avenue, Didcot, Oxfordshire OX11 0DF
United Kingdom
Phone: +44.18.6581.8808
Number of Employees: 107


Vaccitech Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.